Peer Review History
| Original SubmissionAugust 17, 2019 |
|---|
|
PONE-D-19-22604 Whole genome sequence and comparative genome analyses of multi-resistant Staphylococcus warneri GD01 isolated from a diseased pig in China PLOS ONE Dear Mr Fu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Nov 17 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Keun Seok Seo, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We understand that you obtained tissue from a diseased pigs for this study. In your Methods section, please provide additional information regarding the source of the animal:(1) name of the company, farm, or store, (2)where the tissue was obtained from the pig and (3) the cause of death. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a complete S. warneri genome sequence, completed using a combination of PacBio and Illumina HiSeq sequencing. The strain is phenotypically and genotypically characterised, and confirmation of species achieved using Average Nucleotide Identity (ANI). While the work has been performed to a high standard, some small adjustments could be made, to make methods/results clearer, and in terms of the ANI analysis to strengthen the conclusion drawn. Major Comments Line 42: “The other part was used for isolation of bacterial colonies”. On what agar? How was the tissue handled/plated? “Certain colonies”. How were these selected? Line 60: “which amplify approximately 1500 bp fragment [12]. Using the NCBI BLAST server”. The authors jump from PCR amplification straight to analysis of the sequence. How was this amplicon sequenced? Line 80: What chemistry was used for PacBio sequencing? Lines 145-148: The authors compare the ANI values of S. warneri against S. epidermidis and S. aureus. But S. warneri is most closely related to S. pasteuri, while S. caprae and S. capitis are also in the same clade as S. warneri/S. pasteuri/S. epidermidis (see phylogeny from Grana-Miraglia et al. 2018 PeerJ). The inclusion of genomes from S. pasteuri, S. caprae and S. capitis in the ANI analysis would be more meaningful. Complete genomes for all three are available via Genbank. Minor Comments Line 58: 16S not 16s Line 74: “Using Trimmomatic”. Version number? Line 88-90: “Taxonomic assignment…. implemented by OrthoANI Tool v0.93.1”. What reference genomes were used for this? Similarly on line 100: “pairwise genome alignments were conducted using BLASTN”. Against what? What references were being BLASTed against? Similarly line 102-103: “Roary v3.12 was employed to cluster orthologous genes and define bacterial pangenome”. Again, what other strains were used to define the pangenome? Line 129: “sequencing of the partial 16S”. Sanger sequencing? Line 168: should this be “six S. warneri”, rather than “six S. aureus”? Line 169: “Of these, 65% were found”. Would be useful to give the actual number of genes here (e.g. Of these, 65% (n= ) were found). Line 266-7: “The presence/absence patterns of these virulence-associated genes across all strains are shown in Figure 3”. Figure 3 only shows 92 genes , not the 183 or 201 mentioned earlier in the paragraph. How were these 92 selected? Line 301: (2166, 887 aa). Is 2166 the locus number? It almost looks like the protein is 2,166,887aa. A locus tag, in front of the number, would be useful here. Line 385: “the positive and negative strains of the GD01 genome”. What does this mean? Reviewer #2: This manuscript provides a succinct description of a complete genome sequence of an opportunistic pathogen S. warneri, of importance to understanding a major source of morbidity and mortality on the planet (S. aureus). They appear to have properly sequenced (Pac Bio + illumina) and assembled the organism and eight plasmids, which is unusual for emerging pathogen samples. The presentation is logical and appropriate. I would have appreciated a more thorough analysis of the plasmids (where did they likely come from?) and am a little surprised there were not more AMR genes on them, but this isn't my paper. Similarly, the grammar would benefit from a careful proofreading (eg. 3rd sentence of the abstract reads "..genome biology of S. warneri has been paid to less attention on the pathogenicity and antibiotic resistance...", instead of something like, "relatively little attention as been paid to the genome biology of S. warneri pathogenicity and antibiotic resistance"). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Whole genome sequence and comparative genome analyses of multi-resistant Staphylococcus warneri GD01 isolated from a diseased pig in China PONE-D-19-22604R1 Dear Dr. Fu, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Keun Seok Seo, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed all previous comments. A few minor suggestions regarding grammar: Fig 1B contains a spelling error in the species name for NCTC7291 (it should be warneri, not warner). Figure 2 should have a lowercase 'w' for warneri. Line 20: should be 'considerable' rather than 'considerably' Line 48: 'has been suggested' rather than 'have been suggested' Line 119: should this be 'minimum read length'? Line 136: I don't think 'collected' is the right word here. Maybe 'included' or 'analysed'. Line 215: 'in total' rather than 'totally' Line 232: 'on average' Line 233: 'in detail' rather than 'detailly' ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-19-22604R1 Whole genome sequence and comparative genome analyses of multi-resistant Staphylococcus warneri GD01 isolated from a diseased pig in China Dear Dr. Fu: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Keun Seok Seo Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .